Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the SWEDEHEART Platform
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Myocardial infarction; Stroke; Thrombosis; Venous thromboembolism
- Focus Adverse reactions
- Acronyms VALIDATE-SWEDEHEART
- 18 May 2017 Status changed from active, no longer recruiting to completed.
- 20 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 20 Sep 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Mar 2017.